Literature DB >> 15683815

Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.

Robin L Jones1, David W Miles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15683815     DOI： 10.1016/S1470-2045(05)01719-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.

Authors:  Almudena Cascales; Francisco Pastor-Quirante; Beatriz Sánchez-Vega; Ginés Luengo-Gil; Javier Corral; Guzmán Ortuño-Pacheco; Vicente Vicente; Francisco Ayala de la Peña
Journal:  Oncologist       Date:  2013-04-10

2.  Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.

Authors:  David Montaigne; Christopher Hurt; Remi Neviere
Journal:  Biochem Res Int       Date:  2012-03-20

Review 3.  Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica-Induced Cardiotoxicity.

Authors:  Jie Zhou; Fu Peng; Xiaoyu Cao; Xiaofang Xie; Dayi Chen; Lian Yang; Chaolong Rao; Cheng Peng; Xiaoqi Pan
Journal:  Front Pharmacol       Date:  2021-03-30       Impact factor: 5.810

Review 4.  MicroRNAs in Cancer Treatment-Induced Cardiotoxicity.

Authors:  Laura Pellegrini; Sara Sileno; Marco D'Agostino; Eleonora Foglio; Maria Cristina Florio; Vincenzo Guzzanti; Matteo Antonio Russo; Federica Limana; Alessandra Magenta
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.